Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response

Immunity

Volumn 43, Issue 3, 2015, Pages 566-578

  Lee, You Jeong ^a   Wang, Haiguang ^a   Starrett, Gabriel J ^b   Phuong, Vanessa ^c   Jameson, Stephen C ^a   Hogquist, Kristin A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 4; STAT6 PROTEIN; ALPHA-GALACTOSYLCERAMIDE; CYTOKINE; GALACTOSYLCERAMIDE;

ANIMAL CELL; ARTICLE; BAGG ALBINO MOUSE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; LYMPHOCYTE; MESENTERY LYMPH NODE; MOUSE; NATURAL KILLER T CELL; NATURAL KILLER T1 CELL; NATURAL KILLER T2 CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STEADY STATE; T LYMPHOCYTE; THYMOCYTE; VASCULAR ACCESS; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CELL CULTURE; CLASSIFICATION; CYTOLOGY; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER; LUNG; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; NONOBESE DIABETIC MOUSE; SPLEEN; T LYMPHOCYTE SUBPOPULATION; THYMUS; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GALACTOSYLCERAMIDES; INTERFERON-GAMMA; INTERLEUKIN-4; LIVER; LUNG; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; ORGAN SPECIFICITY; SPLEEN; T-LYMPHOCYTE SUBSETS; THYMOCYTES; THYMUS GLAND;

EID: 84941745150     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.06.025     Document Type: Article

References (53)

1. An D., Oh S.F., Olszak T., Neves J.F., Avci F.Y., Erturk-Hasdemir D., Lu X., Zeissig S., Blumberg R.S., Kasper D.L. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell 2014, 156:123-133.
2. Anderson K.G., Mayer-Barber K., Sung H., Beura L., James B.R., Taylor J.J., Qunaj L., Griffith T.S., Vezys V., Barber D.L., Masopust D. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 2014, 9:209-222.
3. Barral P., Polzella P., Bruckbauer A., van Rooijen N., Besra G.S., Cerundolo V., Batista F.D. CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat. Immunol. 2010, 11:303-312.
4. Barral P., Sánchez-Niño M.D., van Rooijen N., Cerundolo V., Batista F.D. The location of splenic NKT cells favours their rapid activation by blood-borne antigen. EMBO J. 2012, 31:2378-2390.
5. Bendelac A., Savage P.B., Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 2007, 25:297-336.
6. Berzins S.P., McNab F.W., Jones C.M., Smyth M.J., Godfrey D.I. Long-term retention of mature NK1.1+ NKT cells in the thymus. J. Immunol. 2006, 176:4059-4065.
7. Carreño L.J., Kharkwal S.S., Porcelli S.A. Optimizing NKT cell ligands as vaccine adjuvants. Immunotherapy 2014, 6:309-320.
8. Castillo E.F., Acero L.F., Stonier S.W., Zhou D., Schluns K.S. Thymic and peripheral microenvironments differentially mediate development and maturation of iNKT cells by IL-15 transpresentation. Blood 2010, 116:2494-2503.
9. Cerovic V., Bain C.C., Mowat A.M., Milling S.W. Intestinal macrophages and dendritic cells: what's the difference?. Trends Immunol. 2014, 35:270-277.
10. Chang P.P., Barral P., Fitch J., Pratama A., Ma C.S., Kallies A., Hogan J.J., Cerundolo V., Tangye S.G., Bittman R., et al. Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat. Immunol. 2012, 13:35-43.
11. Constantinides M.G., Bendelac A. Transcriptional regulation of the NKT cell lineage. Curr. Opin. Immunol. 2013, 25:161-167.
12. Coquet J.M., Chakravarti S., Kyparissoudis K., McNab F.W., Pitt L.A., McKenzie B.S., Berzins S.P., Smyth M.J., Godfrey D.I. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc. Natl. Acad. Sci. USA 2008, 105:11287-11292.
13. Doisne J.M., Becourt C., Amniai L., Duarte N., Le Luduec J.B., Eberl G., Benlagha K. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. J. Immunol. 2009, 183:2142-2149.
14. Doisne J.M., Soulard V., Bécourt C., Amniai L., Henrot P., Havenar-Daughton C., Blanchet C., Zitvogel L., Ryffel B., Cavaillon J.M., et al. Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria. J. Immunol. 2011, 186:662-666.
15. Drennan M.B., Franki A.S., Dewint P., Van Beneden K., Seeuws S., van de Pavert S.A., Reilly E.C., Verbruggen G., Lane T.E., Mebius R.E., et al. Cutting edge: the chemokine receptor CXCR3 retains invariant NK T cells in the thymus. J. Immunol. 2009, 183:2213-2216.
16. Egawa T., Eberl G., Taniuchi I., Benlagha K., Geissmann F., Hennighausen L., Bendelac A., Littman D.R. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity 2005, 22:705-716.
17. Engel I., Kronenberg M. Transcriptional control of the development and function of Vα14i NKT cells. Curr. Top. Microbiol. Immunol. 2014, 381:51-81.
18. Fontenot J.D., Dooley J.L., Farr A.G., Rudensky A.Y. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 2005, 202:901-906.
19. Furlan R., Bergami A., Cantarella D., Brambilla E., Taniguchi M., Dellabona P., Casorati G., Martino G. Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma. Eur. J. Immunol. 2003, 33:1830-1838.
20. Gerner M.Y., Kastenmuller W., Ifrim I., Kabat J., Germain R.N. Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes. Immunity 2012, 37:364-376.
21. Giaccone G., Punt C.J., Ando Y., Ruijter R., Nishi N., Peters M., von Blomberg B.M., Scheper R.J., van der Vliet H.J., van den Eertwegh A.J., et al. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clinical cancer research: an official journal of the American Association for Cancer Research 2002, 8:3702-3709.
22. Gordy L.E., Bezbradica J.S., Flyak A.I., Spencer C.T., Dunkle A., Sun J., Stanic A.K., Boothby M.R., He Y.W., Zhao Z., et al. IL-15 regulates homeostasis and terminal maturation of NKT cells. J. Immunol. 2011, 187:6335-6345.
23. Gray E.E., Friend S., Suzuki K., Phan T.G., Cyster J.G. Subcapsular sinus macrophage fragmentation and CD169+ bleb acquisition by closely associated IL-17-committed innate-like lymphocytes. PLoS ONE 2012, 7:e38258.
24. He Y.W., Deftos M.L., Ojala E.W., Bevan M.J. RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 1998, 9:797-806.
25. Holzapfel K.L., Tyznik A.J., Kronenberg M., Hogquist K.A. Antigen-dependent versus -independent activation of invariant NKT cells during infection. J. Immunol. 2014, 192:5490-5498.
26. Irla M., Guenot J., Sealy G., Reith W., Imhof B.A., Sergé A. Three-dimensional visualization of the mouse thymus organization in health and immunodeficiency. J. Immunol. 2013, 190:586-596.
27. Kaser A., Zeissig S., Blumberg R.S. Inflammatory bowel disease. Annu. Rev. Immunol. 2010, 28:573-621.
28. King I.L., Amiel E., Tighe M., Mohrs K., Veerapen N., Besra G., Mohrs M., Leadbetter E.A. The mechanism of splenic invariant NKT cell activation dictates localization in vivo. J. Immunol. 2013, 191:572-582.
29. Kovalovsky D., Uche O.U., Eladad S., Hobbs R.M., Yi W., Alonzo E., Chua K., Eidson M., Kim H.J., Im J.S., et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 2008, 9:1055-1064.
30. Lee P.T., Putnam A., Benlagha K., Teyton L., Gottlieb P.A., Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 2002, 110:793-800.
31. Lee Y.J., Holzapfel K.L., Zhu J., Jameson S.C., Hogquist K.A. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 2013, 14:1146-1154.
32. Loh L., Ivarsson M.A., Michaëlsson J., Sandberg J.K., Nixon D.F. Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine. Mucosal Immunol. 2014, 7:1233-1243.
33. Lynch L., Michelet X., Zhang S., Brennan P.J., Moseman A., Lester C., Besra G., Vomhof-Dekrey E.E., Tighe M., Koay H.F., et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nat. Immunol. 2015, 16:85-95.
34. Michel M.L., Keller A.C., Paget C., Fujio M., Trottein F., Savage P.B., Wong C.H., Schneider E., Dy M., Leite-de-Moraes M.C. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med. 2007, 204:995-1001.
35. Miyamoto K., Miyake S., Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001, 413:531-534.
36. Moran A.E., Holzapfel K.L., Xing Y., Cunningham N.R., Maltzman J.S., Punt J., Hogquist K.A. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 2011, 208:1279-1289.
37. Olszak T., An D., Zeissig S., Vera M.P., Richter J., Franke A., Glickman J.N., Siebert R., Baron R.M., Kasper D.L., Blumberg R.S. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012, 336:489-493.
38. Pabst O., Mowat A.M. Oral tolerance to food protein. Mucosal Immunol. 2012, 5:232-239.
39. Pellicci D.G., Uldrich A.P., Kyparissoudis K., Crowe N.Y., Brooks A.G., Hammond K.J., Sidobre S., Kronenberg M., Smyth M.J., Godfrey D.I. Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramide. Eur. J. Immunol. 2003, 33:1816-1823.
40. Sag D., Krause P., Hedrick C.C., Kronenberg M., Wingender G. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J. Clin. Invest. 2014, 124:3725-3740.
41. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
42. Savage A.K., Constantinides M.G., Han J., Picard D., Martin E., Li B., Lantz O., Bendelac A. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 2008, 29:391-403.
43. Silk J.D., Hermans I.F., Gileadi U., Chong T.W., Shepherd D., Salio M., Mathew B., Schmidt R.R., Lunt S.J., Williams K.J., et al. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J. Clin. Invest. 2004, 114:1800-1811.
44. Singh M., Quispe-Tintaya W., Chandra D., Jahangir A., Venkataswamy M.M., Ng T.W., Sharma-Kharkwal S., Carreño L.J., Porcelli S.A., Gravekamp C. Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy. Br. J. Cancer 2014, 111:1945-1954.
45. Sullivan B.A., Nagarajan N.A., Wingender G., Wang J., Scott I., Tsuji M., Franck R.W., Porcelli S.A., Zajonc D.M., Kronenberg M. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells. J. Immunol. 2010, 184:141-153.
46. Terashima A., Watarai H., Inoue S., Sekine E., Nakagawa R., Hase K., Iwamura C., Nakajima H., Nakayama T., Taniguchi M. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J. Exp. Med. 2008, 205:2727-2733.
47. Thomas S.Y., Scanlon S.T., Griewank K.G., Constantinides M.G., Savage A.K., Barr K.A., Meng F., Luster A.D., Bendelac A. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J. Exp. Med. 2011, 208:1179-1188.
48. van den Elzen P., Garg S., León L., Brigl M., Leadbetter E.A., Gumperz J.E., Dascher C.C., Cheng T.Y., Sacks F.M., Illarionov P.A., et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 2005, 437:906-910.
49. Venkataswamy M.M., Ng T.W., Kharkwal S.S., Carreño L.J., Johnson A.J., Kunnath-Velayudhan S., Liu Z., Bittman R., Jervis P.J., Cox L.R., et al. Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells. PLoS ONE 2014, 9:e108383.
50. Watarai H., Sekine-Kondo E., Shigeura T., Motomura Y., Yasuda T., Satoh R., Yoshida H., Kubo M., Kawamoto H., Koseki H., Taniguchi M. Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biol. 2012, 10:e1001255.
51. Webster K.E., Kim H.O., Kyparissoudis K., Corpuz T.M., Pinget G.V., Uldrich A.P., Brink R., Belz G.T., Cho J.H., Godfrey D.I., Sprent J. IL-17-producing NKT cells depend exclusively on IL-7 for homeostasis and survival. Mucosal Immunol. 2014, 7:1058-1067.
52. White A.J., Jenkinson W.E., Cowan J.E., Parnell S.M., Bacon A., Jones N.D., Jenkinson E.J., Anderson G. An essential role for medullary thymic epithelial cells during the intrathymic development of invariant NKT cells. J. Immunol. 2014, 192:2659-2666.
53. Wingender G., Stepniak D., Krebs P., Lin L., McBride S., Wei B., Braun J., Mazmanian S.K., Kronenberg M. Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology 2012, 143:418-428.